Cellyan Biotechnology Co. , Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China.
Hong Kong Pharma Digital Technology Holdings stock last closed at $0.86, up 7.12% from the previous day, and has decreased 57.73% in one year. It has underperformed other stocks in the Pharmaceutical Retailers industry by 0.32 percentage points. Hong Kong Pharma Digital Technology Holdings stock is currently +26.18% from its 52-week low of $0.68, and -68.91% from its 52-week high of $2.76.
At the moment, there are 11M HKPD shares outstanding. The market capitalization of HKPD is $9.44M. In the past 24 hours, 14,900 HKPD shares were traded.
You need a brokerage account to access the NASDAQ market and buy HKPD shares.
We believe that eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, the next step is to fill out some personal details so you can invest in HKPD today.
Now that you have opened your account on apps for stock market, you need to deposit funds:
Watch the tutorial below for more details transferring money into your new brokerage account.
Once you have decided on the best place to buy Hong Kong Pharma Digital Technology Holdings stock, it's critical to analyze their stock before you invest, so you can wrap your head around the risk as well as the upside.
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on HKPD's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge HKPD's fair value.
Using relative valuations methods:
You can access additional valuation analysis on HKPD's stock here.
Last year, HKPD revenue was $20.31M. During the last 2 year, HKPD's revenue has grown by 27.2% per year. This was faster than the Pharmaceutical Retailers industry average of 19.49%.
Find out more about HKPD's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at HKPD have not bought or sold any shares.
Learn more about who owns HKPD stock here.
No, Hong Kong Pharma Digital Technology Holdings doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two main options:
Click the Open Trade button and your broker will execute the order.
If you want more help with investing in stocks on eToro, click the helpful video below:
Now that you own some HKPD shares, you'll want to stay up-to-date on your shares.
Start a watchlist to keep tabs on your HKPD stock.
To reiterate, here are the 6 steps you need to take to buy Hong Kong Pharma Digital Technology Holdings stock right now:
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep tabs on your new investment in Hong Kong Pharma Digital Technology Holdings, click the button below.